Halli Miller

Ms. Halli Miller

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
WXWenwen Xu
Wenwen Xu
JDJuan Dong
Juan Dong
YZYongwei Zheng
Yongwei Zheng
JZJuan Zhou
Juan Zhou
YYYing Yuan
Ying Yuan
LWLi Lily Wang
Li Lily Wang
Immune-checkpoint protein V-domain immunoglobulin suppressor of T-cell activation (VISTA) controls antitumor immunity and is a valuable target for cancer immunotherapy. This study identified a role of VISTA in regulating Toll-like receptor (TLR) signaling in myeloid cells and controlling myeloid cell–mediated inflammation and immunosuppression. VISTA modulated the polyubiquitination and protein expression of TRAF6. Consequently, VISTA dampened TLR-mediated activation of MAPK/AP-1 and IKK/NF-κB signaling cascades. At cellular levels, VISTA regulated the effector functions of myeloid-derived suppressor cells and tolerogenic dendritic cell (DC) subsets. Blocking VISTA augmented their ability to produce proinflammatory mediators and diminished their T cell–suppressive functions. These myeloid cell–dependent effects resulted in a stimulatory tumor microenvironment that promoted T-cell infiltration and activation. We conclude that VISTA is a critical myeloid cell–intrinsic immune-checkpoint protein and that the reprogramming of tolerogenic myeloid cells following VISTA blockade promotes the development of T cell–mediated antitumor immunity.

3 May 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LLLina Li
Lina Li
WXWenwen Xu
Wenwen Xu
YYYing Yuan
Ying Yuan
NANatarajan Ayithan
Natarajan Ayithan
Yasutomo ImaiYasutomo Imai
Yasutomo Imai
LWLi Wang
Li Wang
V-domain Immunoglobulin Suppressor of T cell Activation (VISTA) is an inhibitory immune-checkpoint molecule that suppresses CD4+ and CD8+ T cell activation when expressed on antigen-presenting cells. Vsir−/− mice developed loss of peripheral tolerance and multi-organ chronic inflammatory phenotypes. Vsir−/− CD4+ and CD8+ T cells were hyper-responsive towards self- and foreign antigens. Whether or not VISTA regulates innate immunity is unknown. Using a murine model of psoriasis induced by TLR7 agonist imiquimod (IMQ), we show that VISTA deficiency exacerbated psoriasiform inflammation. Enhanced TLR7 signaling in Vsir−/− dendritic cells (DCs) led to the hyper-activation of Erk1/2 and Jnk1/2, and augmented the production of IL-23. IL-23, in turn, promoted the expression of IL-17A in both TCRγδ+ T cells and CD4+ Th17 cells. Furthermore, VISTA regulates the peripheral homeostasis of CD27− γδ T cells and their activation upon TCR-mediated or cytokine-mediated stimulation. IL-17A-producing CD27− γδ T cells were expanded in the Vsir−/− mice and amplified the inflammatory cascade. In conclusion, this study has demonstrated that VISTA critically regulates the inflammatory responses mediated by DCs and IL-17-producing TCRγδ+ and CD4+ Th17 T cells following TLR7 stimulation. Our finding provides a rationale for therapeutically enhancing VISTA-mediated pathways to benefit the treatment of autoimmune and inflammatory disorders.

1 May 2019 in Tuberculosis
Verified
Journal Article
Closed access
HMHalli Miller
Halli Miller
KJKaitlin E. Johnson
Kaitlin E. Johnson
VTVera L. Tarakanova
Vera L. Tarakanova
RRRichard T. Robinson
Richard T. Robinson

13 March 2013 in Tuberculosis
Verified
Journal Article
Closed access
ARAllison E. Reeme
Allison E. Reeme
HMHalli Miller
Halli Miller
RRRichard T. Robinson
Richard T. Robinson

1 March 2014 in Applied Biosafety
Verified
Journal Article
Open access
HMHalli Miller
Halli Miller
SPShane Patzlsberger
Shane Patzlsberger
DRDiane J. Rodi
Diane J. Rodi
RRRichard T. Robinson
Richard T. Robinson
Biosafety Level 2 (BSL-2) and Biosafety Level 3 (BSL-3) facility lab personnel routinely perform procedures that are capable of producing respirable aerosols. While these procedures are considered safe when performed in the closed environment of a biosafety cabinet (BSC), there are, nevertheless, limited data regarding the nature of the aerosols these procedures produce. This lack of aerosol data poses a significant challenge to biosafety professionals, who are charged with assessing the risks associated with handling infectious materials and communicating the importance of proper engineering controls to BSL-2/BSL-3 facility staff. This article characterizes the extent and nature of respirable aerosols produced during routine laboratory procedures when these procedures are performed in an open environment (i.e., outside a BSC). As demonstrated, homogenization, vortexing, and pipetting each produce aerosols of differing characteristics and aerogenic potentials. These characteristics have led to the development of an Exposure Risk Model for routine lab methods to assist biosafety professionals in their efforts to prevent inhalation exposures.

11 March 2025 in Viruses
Verified
Journal Article
Open access
PDF file
HMH Mei
H Mei
HCHongyi Cai
Hongyi Cai
FLFengjie Liu
Fengjie Liu
RVRajkumar Venkatadri
Rajkumar Venkatadri
HMHalli Miller
Halli Miller
RBRavit Boger
Ravit Boger
Cardiac glycosides (CGs), historically used to treat heart failure and arrhythmias, bind to the α subunit of the Na+/K+-ATPase pump and inhibit its activity. Their anticancer and antiviral activities are of interest. The α subunit of the Na+/K+-ATPase pump has four isoforms (α1–4), each with unique tissue distribution and expression pattern; their contributions to antiviral activities have not been studied. We previously reported that CGs inhibit human CMV (HCMV) in vitro but not mouse CMV (MCMV). In addition to the low affinity of mouse α1 for CGs, we hypothesized that other isoforms contribute to the anti-CMV activities of CGs. We show here that infection with HCMV significantly induced α3 in human foreskin fibroblasts, while MCMV did not induce mouse α3. Infection with guinea pig CMV (GPCMV) in GP fibroblasts also induced α3, and CGs inhibited GPCMV replication. HCMV inhibition with digitoxin reduced α3 expression. The concentration-dependent inhibition of HCMV with digitoxin analogs also correlated with α3 expression. Intriguingly, α3 was localized to the nucleus, and changes in its expression during infection and digitoxin treatment were mostly limited to the nucleus. At 4 h post-infection, α3 colocalized with immediate early 1 (IE1) and the promyelocytic leukemia protein (PML). An interaction of α3-PML-IE1 at 24 h post-infection was disrupted by digitoxin. The mRNA levels of IE1, major immediate early promoter (MIEP)-derived IE, and antiviral cytokines were reduced in infected digitoxin-treated cells. Summarized, these findings suggest a new role for α3 in the anti-HCMV activities of CGs via nuclear antiviral signaling pathways.